What is the relative clinical and cost effectiveness of PET/CT compared with alternate diagnostic imaging modalities in the investigation of paraneoplastic syndromes (PNS)? Assuming diagnosis using PET/CT is clinically and cost effective, at what stage should it be used in the diagnostic pathway? : in response to an enquiry from the PET short-life working group.
Healthcare Improvement Scotland.
"October 2013."
Includes bibliographical references (page 6).
System requirements: Adobe Reader required to view PDF document.
Description from online resource; title from PDF caption (Healthcare Improvement Scotland, viewed 20 February 2020).
Paraneoplastic syndromes
Tomography, Emission